T1	Participants 530 571	This study was nested in the IMPALA study
T2	Participants 613 662	involving 24 general practices in The Netherlands
T3	Participants 782 886	421 patients without established cardiovascular diseases but eligible for cardiovascular risk assessment
T4	Participants 1380 1396	Elderly patients
T5	Participants 1423 1448	male patients (vs. female
T6	Participants 1478 1511	smoking patients (vs. non-smoking
T7	Participants 1602 1689	Ten (28%) of the 36 patients who should be assigned to the high-risk treatment category
